The Trans Pacific Partnership (TPP) Agreement will open up vast new markets for Australian companies, including manufacturers of innovative medicines and vaccines, Medicines Australia CEO, Tim James, said today. “Pharmaceuticals are already one of Australia’s largest manufactured export, worth around $3 billion each year," he says. “But a new trade deal which further reduces trade
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.